ALS Nexus 2026: Uniting the Global Community in the Fight Against ALS
The ALS Association proudly announces the return of
ALS Nexus, the premier annual conference dedicated to advancing the fight against
amyotrophic lateral sclerosis (ALS). Scheduled from
August 23 to 26, 2026, at the
Hyatt Regency Grand Cypress Resort in
Orlando, Florida, this year's conference promises to be a significant gathering, where innovators and advocates in the field will join forces. For those unable to attend in person, a virtual attendance option is also available, ensuring global participation.
Bringing Together the ALS Community
ALS Nexus serves not merely as a conference but as a collaborative hub where leaders in ALS research, clinical care, and advocacy converge with individuals living with ALS and their caregivers. This event intends to foster connections, promote collaboration, and catalyze changes that could influence the future landscape of ALS care and research.
Calaneet Balas, President and CEO of the ALS Association, emphasizes the critical importance of this conference, stating, "For people living with ALS, time is everything — and ALS Nexus is where we turn that urgency into progress." This ethos captures the essence of the conference — a commitment to working together to expedite advancements in ALS treatment and care.
Inspirational Sessions and Highlights
The
2026 Agenda is rich with groundbreaking sessions that highlight advancements in ALS research, diagnostic measures, and caregiving approaches. Among the notable sessions:
Keynote: Finding Hope
A standout event will be the
plenary session titled
Finding Hope, featuring an intimate fireside chat between Calaneet Balas and prominent actress and advocate
Tabitha Brown. Drawing from her personal experiences with ALS, Brown will share her insights on resilience and hope amidst adversity. Her conversation with Balas is expected to inspire those affected by the disease and provide practical strategies for maintaining hope and positivity while navigating the challenges of ALS.
Emerging Science from Young Innovators
Another key session will showcase
next-generation ALS researchers. Notable speakers, including Dr. Jill Goslinga, whose personal connection to ALS fuels her research, will lead discussions on cutting-edge discoveries and treatment methodologies. This session aims to illuminate the pathway forward through scientific innovation, showcasing work from esteemed institutions like
Johns Hopkins University and
Harvard T.H. Chan School of Public Health.
Navigating Insurance Barriers
A pragmatic session titled
Winning Appeals will address the increasingly common issue of insurance denials impacting ALS care. Experts will provide strategies on crafting effective appeal letters and leveraging clinical documentation to support claims. This session aims to empower both patients and clinicians to navigate hurdles effectively, ensuring timely access to necessary treatments and interventions.
Celebrating ALS Heroes
A hallmark of ALS Nexus is honoring the
ALS Heroes, individuals nominated by the community whose passion and perseverance represent the spirit of the fight against ALS. They embody resilience and serve as beacons of hope for many.
Registration and Participation
ALS Nexus 2026 promises to be a transformative event open to all members of the ALS community, emphasizing the importance of collective effort in combating the disease.
Registration is required, whether attending in person at the Hyatt Regency Grand Cypress Resort or virtually. Due to limited space, early registration is encouraged to secure your participation.
For a complete agenda and further details, visit
alsnexus.org.
About the ALS Association
The
ALS Association stands as the largest ALS organization globally, leading the charge in funding research, providing resources for affected individuals and families, and advocating for impactful public policies. Their mission is clear: to make ALS a livable disease while actively searching for new treatments and a cure. For more information, visit
als.org.
Understanding ALS
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that progressively inhibits muscle control, ultimately leading to loss of movement, speech, and breathing. It is a fatal condition with few existing treatment options, underscoring the urgency and necessity for continued research and innovative approaches to care.